Purpose To investigate the diagnostic value of the Prostate Imaging Reporting and Data
System version 2.1 (PI-RADS v2. 1) for clinically significant prostate cancer (CsPCa). We …

Purpose The diagnostic performance of the Prostate Imaging Reporting and Data System
version 2 (PI-RADS v2) has been challenged due to its lower diagnostic accuracy and …

Objectives The purpose of this study is to evaluate the diagnostic accuracy of the clinical
variables of patients with prostate cancer (PCa) and to provide a strategy to reduce …

Prostate cancer (PCa) is one of the most common cancers among men globally. The authors
aimed to evaluate the ability of the Prostate Imaging Reporting and Data System version 2 …

Background Our objective is to build a model based on Prostate Imaging Reporting and
Data System version 2 (PI-RADs v2) and assess its accuracy by internal validation. Methods …

Background Any non-invasive test that can predict the absence of prostate cancer (PCa) or
absence of clinically significant PCa (CSPCa) is necessary, as it can reduce the number of …

Background To establish a new accumulating model to enhance the accuracy of prostate
cancer (PCa) diagnosis by incorporating prostate-specific antigen (PSA) and its derivative …

The main purpose of Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2)
is to effectively detect clinically significant prostate cancers (csPCa) using multiparametric …

The diagnostic accuracy of clinically significant prostate cancer (csPCa) of Prostate Imaging
Reporting and Data System version 2 (PI-RADSv2) is limited by subjectivity in result …

Introduction Multiparametric magnetic resonance imaging (mpMRI) has been shown to have
a good performance in predicting cancer among patients with a prostate-specific antigen …